Abstract:AIM: To investigate the anti-human hepatocellular car-cinoma (HCC) activity of docetaxel and determine the potential radiosensitizing effect of docetaxel in vivo, and to further explore the mechanism of docetaxel-induced cell growth inhibition, apoptosis and radiosen-sitization at gene level.METHODS: Nude mice bearing HCC with a diameter of about 0.8 cm in the leg received 33 mg/kg docetaxel intraperitoneally, 10 Gy (5 Gy once) tumor irradiation, or both (radiation given 24 and 48 h after docetaxel treatment). The regression and regrowth of the tumors were followed until the tumor diameter reached 1.4 cm approximately. Absolute growth delay (AGD), which was defi ned as the time in days for tumors treated with docetaxel to grow from 0.8 to 1.4 cm in diameter mi-nus the time in days for untreated tumors to reach the same size, was used to evaluate the antitumor effect ofdocetaxel. Normalized growth delay (AGD), which was def ined as the time in days for tumors treated with both docetaxel and irradiation to grow from 0.8 to 1.4 cm in diameter minus the time in days for tumors treated with docetaxel alone to reach the same size, and the en-hancement factor (ratio of NGD to AGD for irradiation alone) was used to assess the effect of the combined docetaxel plus radiation treatment. Real-time qutitative reverse transcription-polymerase chain reaction (RT-PCR) was performed to detect the expression of bcl-2 and p21 genes in HCC cells before and after decetaxel treatment.RESULTS: The tumors in docetaxel treated alone and irradiation treated alone groups needed 35 and 29 d to reach 14 cm in diameter, respectively, while the ones in the control group needed 23 d. So the AGD was 12 and 6 d, respectively. The combined administra-tion of docetaxel and irradiation resulted in signifi cant growth delay (47 d), and the EF was 2.0, indicating that docetaxel enhanced tumor radioresponse. At 20 d, the sizes of the tumors in docetaxel treated alone group and combination of docetaxel and irradiation group were significantly smaller than those in the controls (P = 0.008, P = 0.005), and the size in the combination group was also smaller than that in the irradiation alone group (P = 0.002). Real time quantita-tive RT-PCR analyses revealed that mRNAs of p21 in the docetaxel treated SMMC-7721 cells at most of the time points were increased, as compared with those in the control cells. In contrast, bcl-2 expression in the docetaxel treated SMMC-7721 cells was suppressed as compared with that in the controls.CONCLUSION: Docetaxel can inhibit the growth of HCC and enhance the tumor response to fractionated irradiation in vivo by down-regulation of bcl-2 expres-sion and up-regulation of p21 expression..

Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis.

Antitumor and radiosensitizing effect of docetaxel on human hepatocellular carcinoma and its mechanisim in vivo

Docetaxel Shows Radiosensitization in Human Hepatocellular Carcinoma Cells

Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy.

Docetaxel Shows Radiosenstization in SMMC-7721 Human Hepatocellular Carcinoma Cells

Cabazitaxel, a Novel Chemotherapeutic Alternative for Drug-Resistant Hepatocellular Carcinoma.

Study on Taxol in Inhibiting Human Leukemia Cell Proliferation and Inducing Apoptosis

Effect of docetaxel on gastric cancer cells and its mechanism

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Apoptosis, Redifferentiation and Arresting Proliferation Simultaneously Triggered by Oxidative Stress in Human Hepatoma Cells

Relationship between the effect of docetaxel inducing apoptosis of non-small-cell lung cancer cell and the intracellular level of reactive oxygen

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Study on Molecular Mechanism about Inhibiting Lung Cancer Cells by Docetaxel Serums from Patients

Immunomodulatory Effects of Docetaxel on Human Lymphocytes

Role of Apoptosis Inhibition in the Multidrug Resistance of the Human Lung Adenocarcinoma Cell Line SPC-A1/Docetaxel

Chrysotoxene Induces Apoptosis of Human Hepatoblastoma HepG2 Cells Inï¿½vitro and Inï¿½vivo Via Activation of the Mitochondria-Mediated Apoptotic Signaling Pathway

Effect of tanshinone II a combined with oxaliplatin on human hepatocellular carcinoma cell line SMMC-7721

Examining clinical trial results with single-subject analysis: an example involving behavioral and nutrition treatment for young children with cystic fibrosis.

Cytotoxic Activity of Anticancer Drugs on Hepatocellular Carcinoma Cells in Hypoxic-Hyponutritional Culture.

Oxaliplatin Induces Apoptosis in Hepatocellular Carcinoma Cells and Inhibits Tumor Growth

The Antitumor Effects Of Cik Cells Combined With Docetaxel Against Drug-Resistant Lung Adenocarcinoma Cell Line Spc-A1/Dtx In Vitro And In Vivo